Can N-Acetylcysteine (NAC) Protect Your Liver After Surgery?
"Exploring the protective effects of NAC on liver health after partial hepatectomy and ischemia-reperfusion injury."
Liver surgery, including partial hepatectomy (removal of a portion of the liver), is sometimes necessary to treat tumors or other liver diseases. However, these procedures can lead to ischemia-reperfusion injury, a condition where the liver is damaged when blood flow is restored after a period of oxygen deprivation. This injury can compromise liver function and overall recovery.
Researchers are constantly seeking ways to minimize this damage and improve patient outcomes. One promising area of investigation involves the use of N-acetylcysteine (NAC), an antioxidant and anti-inflammatory agent known for its protective effects on various tissues, including the liver.
This article explores the findings of a study investigating the effects of NAC on liver ischemia-reperfusion injury following partial hepatectomy in mice, offering insights into how NAC may promote liver health and recovery after surgery.
What the Evidence Examines
A 2023 systematic review and meta-analysis of randomized clinical trials examined whether NAC administration could change liver function, based on its antioxidant and anti-inflammatory activities. Research has also evaluated NAC in metabolic dysfunction–associated steatotic liver disease (MASLD): a study published August 12, 2026, assessed high-dose NAC and oxidative stress, insulin resistance, and liver-related outcomes in non-diabetic patients. For nonalcoholic fatty liver disease (NAFLD), a 2023 paper noted that NAC’s therapeutic potential remained unclear. Evidence for liver injury from causes other than paracetamol toxicity was described as limited in a 2020 trial report on anti-tuberculosis therapy.
From Mucolytic to Antidote
N-acetylcysteine’s clinical use began as a mucolytic agent in the 1960s. The rise in acetaminophen-overdose-related hepatotoxicity during the 1960s and 1970s prompted a search for an antidote. NAC is a derivative of cysteine, with an acetyl group attached to the amino acid’s nitrogen end. A technical guide describes its development from a mucolytic agent into a compound studied for antioxidant, anti-inflammatory, and neuromodulatory properties.
How Does NAC Help the Liver?
A study published in Acta Cirurgica Brasileira investigated the potential benefits of NAC in protecting the liver after a 30% hepatectomy (surgical removal of part of the liver) followed by ischemia-reperfusion injury in mice. The researchers aimed to determine if NAC could reduce liver damage and promote healing in this setting.
- ALT and AST levels: These are enzymes released into the bloodstream when liver cells are damaged.
- Histological analysis: Microscopic examination of liver tissue to assess structural damage, inflammation, and fat infiltration.
- Mitogenic activity: Measured by counting binuclear hepatocytes (liver cells with two nuclei), which indicates cell regeneration.
NAC in Liver Ischemia–Reperfusion Research
Research cited in a paper on steatohepatitis-associated hepatic ischemia–reperfusion (I/R) reports enzymatic and morphological protective effects in the liver after NAC treatment in a hepatectomy model. Related studies cited in the provided material include liver I/R injury after 30% hepatectomy and a rat partial-hepatectomy experiment that used 30 minutes of ischemia followed by 60 minutes of reperfusion. These findings concern experimental settings; the supplied sources do not establish that NAC protects people’s livers after surgery.
The Future of NAC in Liver Care
This research suggests that N-acetylcysteine (NAC) holds promise as a protective agent for the liver following partial hepatectomy and ischemia-reperfusion injury. By reducing inflammation, minimizing structural damage, and promoting liver regeneration, NAC may contribute to improved outcomes for patients undergoing liver surgery.
Potential Beyond NAC’s Listed Use
N-acetylcysteine is listed on the Essential Medicines List for exposure to, or harmful effects of undetermined intent from, analgesics, antipyretics, or nonsteroidal anti-inflammatory drugs. A 2024 review describes liver diseases as a worldwide health problem associated with two million deaths per year and identifies oxidative stress as important in their development. That review reports evidence of NAC’s effectiveness in preventing liver damage in experimental and clinical studies, attributing its pharmacodynamic mechanisms to antioxidant activity. This broader discussion does not specifically establish a role in preventing liver injury after surgery.
A Case for Further Clinical Study
A 2024 review concludes that, based on the literature it assessed, NAC could be an appropriate option to investigate in clinical studies related to hepatic injury. It also describes repurposing NAC to treat liver diseases as a possible future direction. A separate 2025 article says NAC has drawn attention for supporting and restoring liver health after toxin exposure, but the supplied material does not establish its effectiveness after surgery.
Investigating NAC in Liver Cancer
NAC is described as a drug used clinically to treat drug-induced liver injury. A 2024 experimental study examined its antioxidant, antifibrogenic, and antiproliferative properties in experimentally induced hepatocellular carcinoma (HCC). The study addressed whether NAC could modulate molecular mechanisms activated during HCC establishment, an ability the source says was not known. These experimental questions concern HCC and do not by themselves show that NAC prevents liver complications after surgery.
Clinical Use and a Reported Case
A 2024 review states that NAC has proven beneficial effects in paracetamol-induced liver failure and is widely used for all forms of acute liver failure. A 2018 case report describes repeated potentially toxic acetaminophen ingestions treated with repeated NAC, with no subsequent hepatic injury. The report characterizes the case as an extreme real-life example, so it should not be taken as evidence that NAC reliably prevents liver injury in other circumstances, including after surgery.
While these findings are encouraging, it's essential to note that this study was conducted on mice. Further research is needed to confirm these results in humans and determine the optimal dosage and timing of NAC administration.
However, the potential benefits of NAC in liver care warrant further investigation. As research progresses, NAC may become a valuable tool for protecting and promoting liver health in various clinical settings.